Granules’ packaging facility in US completes FDA inspection with zero observations
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Growing patent filings and tier-2 innovators reflect expanding national research base
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
The audit was completed with zero critical and zero major observations
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
Clinical trials found that 77% of patients went into remission after receiving obe-cel
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
Subscribe To Our Newsletter & Stay Updated